BIOC Archives - Page 5 of 7 - Blue Horseshoe Stocks

Blue Horseshoe Stocks: GLBS Recap & More

Globus Maritime Ltd. GLBS – Update

GLBS was among the shipping sector plays that we were talking about in Friday morning’s premarket report, and it ultimately ended up being the most interesting one of the bunch. The sector as a whole seemed to be buzzing leading into Friday, and the activity that coincided in the GLBS chart, which made several tradeable swings on the day.

It started from the opening bell when the stock initially ran impressively from .66-1.63 for gains of up to 147% right off the bat. We then observed a pullback whereafter the stock bounced from .95 on up to the high of day at 1.78; that added an 87% rip. Subsequent to that, yet another dip and rip carried from .97-1.41, tacking on another 45% upswing. In total, cumulative single-session gains for GLBS came in at 279% as the stock traded record volume.

We often search for plays with volatility of this magnitude because they can be excellent for quick intraday flips as GLBS demonstrated on Friday. We’ll be interested to see how it establishes itself as things get going this week. More opportunities may be on the horizon.

Bottom Watchlist

The following trio of stocks caught our interest off of our bottom-play scan this morning. In the case of RCPI we’ve got a stock that’s been steadily beaten back into heavily oversold territory, while BIOC and STX have both violently gapped down in recent sessions. We’ll have all three on extended watch for potential bounce-play opportunities.

Rock Creek Pharmaceuticals, Inc. RCPI
Biocept Pharmaceuticals,Inc. BIOC
Seagate Technology Public Ltd. Co. STX

We’ve also included a conglomerate snapshot of all three charts:

Extended Watchlist:
SPOM, SRNA, SRPT, LBSR, GOFF

Blue Horseshoe Stocks: CLTX Recap & More

Celsus Therapeutics Plc. CLTX

The big winner from yesterday’s report turned out to be CLTX. We tagged the stock after catching it on a routine news scan; the company announced an all-stock exchange agreement with Volution Immuno Pharmaceuticals in which CLTX will absorb the company as a wholly-owned subsidiary, and form a new company aimed at developing treatments for a range of rare and orphan autoimmune and inflammatory diseases >> READ PR

Back in February, a bleak annual report led CLTX to fall off of a cliff, tumbling from the $6+ range down to roughly a dollar. Over the next several months, the stock continued to trend downward, culminating in a 52-week low of .40 at the end of May. Since that time, it received a little boost, rising to the .60-range.

That’s where we came upon it yesterday, and it was fortunate that we began paying attention when we did. After dipping to a daily low of .5012, the stock ran into the close, reaching a high of .68; a solid 36% intraday move. The late boost of momentum is carrying over into the premarket today, with CLTX hitting an early high of .99. From our observed low yesterday, that’s a 98% swing.

We’ll look for it to continue to build its base with higher lows, and to potentially crack through resistance into dollar-territory.

Callaway Golf Co. ELY

ELY is contributing to the newsreel this morning, announcing the signing of a highly talented young golfer. Upon taking notice of this, we’ve also seen that ELY has been building a heck of a chart setup over the past few sessions.

The stock has registered higher lows for each of the last four consecutive trading sessions, and is exhibiting a great deal of promise with regard to a number of bullish signals on the chart that we’ve pointed out on the snapshot below. Between that, and it being the peak of golf season, we’ll be paying close attention to ELY.

CARLSBAD, Calif., July 14, 2015 /PRNewswire/ — Today Callaway Golf officially announced that it has reached a Staff Pro agreement with former college golf phenom, Julien Brun. A native of Anitbes, France, Brun turns pro after an unbelievable career at Texas Christian University (TCU), where he was a 3-time First Team All-American and a 3-time Academic All-American.>> FULL PR

EnteroMedics, Inc. ETRM

Speaking of ripening charts, we’ve got to tag ETRM this morning as a bottom-play that could be in line for a serious rebound. One look at the chart is all it takes to see what we mean.

We’ve got an egregiously oversold RSI, and the stock has fallen to new 52-week lows in the past couple of sessions. There are also a couple of gaps to fill from 44-.50 and from .83-.96 on a possible retrace, so we’ll be monitoring this play which we feel has breakout potential based on these factors.

Extended Watchlist:
BIOC, CLSN, TBIO, CEL, VLTC, CPXX

Blue Horseshoe Stocks: SPHS, OPXA, PPCH Highlights

Sophiris Bio, Inc. SPHS

SPHS was the first mention from yesterday’s morning report to grab our attention with an early surge that provided the chance at a rapid, substantial gain. From the low-of-day at 1.02, the stock made a big move to 1.64; an increase of 60% inside of the first half-hour of the session. The bulk of the day’s volume, which came in at more than 18X the three-month average, traded in that short time-span as well.

In addition to the heavy volume, making its biggest moves early in the trading day seems to be an established pattern with SPHS, so we’ll have an eye peeled as the session commences today.

Opexa Therapeutics, Inc. OPXA

The other standout from yesterday’s report was OPXA, which spiked on word of coverage initiation by large investment banking and research firm, Maxim Group. (>>View PR)

From its daily low of .43, the stock stair-stepped its way up throughout the session and eventually hit a high of .54; an intraday gain of 26% As it appears to gapping up in the premarket and has already touched .58, the total increase we’ve seen gets pushed to 35% We’ll be interested to follow the impending activity as well as check out the CEO’s presentation which we detail below.

Per a news release from last week, “Neil K. Warma, President and Chief Executive Officer, will present at the 2015 Marcum Microcap Conference on Thursday, May 28, 2015, at 11:30 a.m. EDT in the Plymouth Room. The conference will be held at the Grand Hyatt New York Hotel in New York, NY. A live webcast of the company presentation can be accessed here, or via the Investor Relations section of the Company’s website at www.opexatherapeutics.com.

Propanc Health Group Corp. PPCH

PPCH is a stock that we began tracking in the second week of March, and over the period of several weeks since that time the stock has made some truly epic moves. Subsequent to our tag of PPCH on March 18th, we observed a low of .0116, followed by an impressive run up to an even dime. That 762% mega-run was followed by a tapering back to a low of .021.

Yesterday the stock soared almost all the way back to its previous high, touching .094, which marks another swing of 348% that we;ve seen from this incredible mover. If the stock can breach that previous swing-high, it’ll be off to the races, so we’ll definitely keep PPCH an item of interest moving forward.

Extended Watchlist:
BIOC, NETE, OHGI, MNGA

Blue Horseshoe Stocks: Recap of Friday & Much More

Friday’s Options Ideas:

We had our eyes on a handful of options trading possibilities on Friday, and we did see some significant moves to the upside emerge from that group. We’ll kick things off this week by outlining some of the opportunities that were available for traders within the price ranges we specified in Friday’s report:

Skyworks Solutions, Inc. SWKS
$94.50 Calls – Range: 1.26-3.63 – Max Gain: 188%
$95 Calls – Range: .84-3.20 – Max Gain: 280%
$95.50 Calls – Range: .60-2.28 – Max Gain: 280%
$96 Calls – Range: .53-2.36 – Max Gain: 345%

Expedia, Inc. EXPE
$99 Calls – Range: 1.43-3.60 – Max Gain: 152%
$99.50 Calls – Range: 2.00-2.83 – Max Gain: 41%

FireEye, Inc. FEYE
05/08 $42 Calls – Range: 1.70-2.55 – Max Gain: 50%
05/08 $43 Calls – Range: 1.25-2.00 – Max Gain: 60%

It’s quite the task for anyone to provide just one worthwhile options-trading idea, and on Friday, we were three for three. It serves as a great example of why we like to mix plenty of these options ideas into our daily reports; the gains are out there, ripe for the taking!

Advanced Medical Isotope Corp. ADMD

Our attention was drawn to ADMD this morning as it popped up on our news scanner; the company has come forth with information regarding an “error in the calculation of common shares that should have properly been issued, resulting in significant excess issuances of common stock”. It essentially boils down to an estimated positive impact of $0.8M on ADMD’s balance sheet.

We naturally took a look at the ADMD chart upon taking notice of this news, and as we point out with the annotations below, there are several indications of a bullish trend in effect. As a result, we’ll want to keep watch over ADMD as we begin this new trading week.

Rebound For Social Media Stocks?

LinkedIn Corp. LNKD and Twitter, Inc. TWTR were both crushed on disappointing earnings last week, and both stocks appear to be gearing up for a possible recovery this week. They’re both slightly in the green here in the premarket this morning, and we’ll be looking for potential swing trade opportunities that might present themselves in coming weeks with Calls bearing a 05/29 expiration date.

On LinkedIn Corp. LNKD we’ll be monitoring the 05/29 $200-210 Call range. The longer period before expiration gives the stock some time to sustain a comeback off of recent lows.

For Twitter, Inc. TWTR we’ll actively monitor the 05/29 $38-42 Call range for similar opportunities.

Extended Watchlist:
PBR, ICLD, ARRY, BIOC, CYNI, SCOK, IBIO, XGTI, NRTI(Potential Bottom-Play)

Blue Horseshoe Stocks: VLTC Recap & More

Voltari Corp. VLTC

A unique opportunity presented itself when billionaire activist investor Carl Icahn disclosed his increased position in VLTC (52% ownership) on April 1st. We tagged the stock in our premarket report that morning as it was gapping up, and have become more and more pleased with that decision as time goes on.

After witnessing a low of 2.18 the following day, it has been mostly northward movement as the stock has slowly but surely made its way to impressive new highs. We’ve been tracking it all along the way, with routine followup mentions on the 8th, 10th, 16th, and again in yesterday’s report.

During yesterday’s session VLTC made a nice move from a low of 8.75 to a new 52-week high of 10.41 at the close. It marked a healthy intraday run of 19%, and represents an overall increase of 377% from our observed low on April 2nd.

Anyone trading in this play has certainly thought of taking profits by this point, and reasonably so. That being said, with a high-profile investor like Icahn involved, we’ll have to be sure we don’t let VLTC slip off of our radars as we go forward.

When we finally do see a consolidation off of this historic run, we’ll immediately transition into bottom-watch mode and lay in wait for a subsequent rebound.

Pazoo, Inc. PZOO

We also want to give a quick update on PZOO, which as our readers are aware, we’ve been tracking pretty heavily in recent weeks. Like VLTC, it was also April 1st that we re-introduced this one into the mix. We’ve witnessed many intraday swings since then, that have offered multiple opportunities for successful trades.

Yesterday, the stock made its way from a daily low .0093 and spiked 18% to a new high of .011. That means that from the low of .0049 we observed on April 6th, PZOO had increased by a total of 124% It also closed at .0105; we’d like to see the stock work toward building a base of support at that key penny-level, however on any potential pullbacks we’ll want to see it hold support at or above the channel between the current 50DMA of .0074 and .008.

As we mentioned yesterday, we’re still rather “high” on marijuana-related stocks and PZOO remains one of our favorite ones, in its unique niche of medical cannabis testing/analysis.

Extended Watchlist:
LRCX, MYL, BIOC, BCLI, IBIO, LRE, TWDL, WSTI